INBX (Inhibrx Biosciences) Price-to-Operating-Cash-Flow : (As of May. 29, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Inhibrx Biosciences Price-to-Operating-Cash-Flow?

As of today (2025-05-29), Inhibrx Biosciences's share price is $13.75. Inhibrx Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-10.98. Hence, Inhibrx Biosciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Inhibrx Biosciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

INBX's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.23
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Inhibrx Biosciences's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $-2.32. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-10.98.

Inhibrx Biosciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Inhibrx Biosciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inhibrx Biosciences Price-to-Operating-Cash-Flow Chart

Inhibrx Biosciences Annual Data

Trend

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Inhibrx Biosciences Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Inhibrx Biosciences's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Inhibrx Biosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inhibrx Biosciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inhibrx Biosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Inhibrx Biosciences's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Inhibrx Biosciences Price-to-Operating-Cash-Flow Calculation

Inhibrx Biosciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	13.75	/	-10.978
	=

Inhibrx Biosciences's Share Price of today is $13.75.
Inhibrx Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.98.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Inhibrx Biosciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Inhibrx Biosciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Inhibrx Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inhibrx Biosciences Inc (NAS:INBX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

11025 N. Torrey Pines Road, Suite 140, La Jolla, CA, USA, 92037

Website

https://www.inhibrx.com

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.